J. Ramos

发表

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

T. Bisogno, V. Di Marzo, F. Berrendero, 1999, Biochemical and biophysical research communications.

Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.

J. Ramos, J. Fernández-Ruiz, M. López-Rodríguez, 2003, Journal of medicinal chemistry.

Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to δ 9-tetrahydrocannabinol

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 1995, Pharmacology Biochemistry and Behavior.

The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons.

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 1995, Life sciences.

Optimization of the pharmacophore model for 5-HT7R antagonism. Design and synthesis of new naphtholactam and naphthosultam derivatives.

L. Pardo, J. Lavandera, J. Ramos, 2003, Journal of medicinal chemistry.

Time‐course of the cannabinoid receptor down‐regulation in the adult rat brain caused by repeated exposure to Δ9‐tetrahydrocannabinol

J. Manzanares, F. Berrendero, J. Ramos, 1998, Synapse.

Cannabinoid receptor binding and mRNA levels in several brain regions of adult male and female rats perinatally exposed to delta9-tetrahydrocannabinol.

J. Ramos, J. Fernández-Ruiz, J. Romero, 1999, Drug and alcohol dependence.

Chronic exposure to morphine, cocaine or ethanol in rats produced different effects in brain cannabinoid CB(1) receptor binding and mRNA levels.

D. Parolaro, J. Ramos, J. Fernández-Ruiz, 2002, Drug and alcohol dependence.

Effects of rimonabant, a selective cannabinoid CB1 receptor antagonist, in a rat model of Parkinson's disease

M. García-Arencibia, J. Ramos, J. Fernández-Ruiz, 2006, Brain Research.

Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats.

C. Guaza, J. Ramos, Maria-Paz Viveros, 2002, Brain research. Developmental brain research.

Increased cannabinoid CB1 receptor binding and activation of GTP‐binding proteins in the basal ganglia of patients with Parkinson's syndrome and of MPTP‐treated marmosets

P. Jenner, M. Cebeira, J. Ramos, 2001, The European journal of neuroscience.

Sex steroid influence on cannabinoid CB(1) receptor mRNA and endocannabinoid levels in the anterior pituitary gland.

J. Manzanares, T. Bisogno, V. Di Marzo, 2000, Biochemical and biophysical research communications.

Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based Neuroprotective Therapies.

J. Ramos, J. Fernández-Ruiz, Mariluz Hernández, 2017, Methods in enzymology.

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

G. Velasco, M. Guzmán, J. Ramos, 2007, Trends in pharmacological sciences.

DRD2 TaqIA polymorphism is associated with urinary homovanillic acid levels in a sample of spanish male alcoholic patients

J. Hoenicka, G. Rubio, T. Palomo, 2009, Neurotoxicity Research.

Association in alcoholic patients between Psychopathic Traits and the additive effect of allelic forms of theCNR1 andFAAH endocannabinoid genes, and the 3′ Region of theDRD2 Gene

J. Hoenicka, G. Rubio, T. Palomo, 2009, Neurotoxicity Research.

Neuronal and Astroglial Response to Pre- and Perinatal Exposure to Delta-9-Tetra- Hydrocannabinol in the Rat Substantia nigra

J. Ramos, J. Fernández-Ruiz, G. Bodega, 2000, Developmental Neuroscience.

Inhibition of Fatty Acid Amidohydrolase, the Enzyme Responsible for the Metabolism of the Endocannabinoid Anandamide, by Analogues of Arachidonoyl-serotonin

J. Ramos, M. López-Rodríguez, A. Viso, 2003, Journal of enzyme inhibition and medicinal chemistry.

Decreased Cannabinoid CB1 Receptor mRNA Levels and Immunoreactivity in Pituitary Tumors Induced by Prolonged Exposure to Estrogens

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 2000, Pituitary.

Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia

C. Vázquez, J. Cabranes, J. Santos, 1989, Biological Psychiatry.

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine

M. Cascio, V. Marzo, F. Fezza, 2002, Brain Research.

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties

M. García-Arencibia, R. Mechoulam, J. Ramos, 2007, Brain Research.

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

V. Marzo, M. Valenti, F. Fezza, 2005, Neurobiology of Disease.

Identification of Endocannabinoids and Cannabinoid CB1 Receptor mRNA in the Pituitary Gland

J. Manzanares, T. Bisogno, V. Di Marzo, 1999, Neuroendocrinology.

J. Ramos, J. Fernández-Ruiz, J. Alemany, 1989, Neurobiology of Aging.

Lack of association between polymorphisms in cannabinoid receptor gene (CNR1) and fatty acid amide hydroxylase gene (FAAH) and eating disorders in a preliminary study.

J. Ramos, I. Ampuero, O. Sagredo, 2009, Psychiatric Genetics.

Pd(0) Amination of Benzimidazoles as an Efficient Method towards New (Benzimidazolyl)piperazines with High Affinity for the 5-HT1A Receptor

J. Ramos, M. López-Rodríguez, A. Viso, 2000 .

Association between cannabinoid receptor gene (CNR1) and childhood attention deficit/hyperactivity disorder in Spanish male alcoholic patients

J. Hoenicka, G. Rubio, T. Palomo, 2003, Molecular Psychiatry.

Comparisons between brain dopaminergic neurons of juvenile and aged rats: Sex-related differences

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 1992, Mechanisms of Ageing and Development.

Fatty acid synthetase complex from the insect Ceratitis capitata.

M. Lizarbe, J. Ramos, Á. M. Municio, 1977, Biochimica et biophysica acta.

Effects of estrogens and progesterone on the catecholaminergic activity of the adrenal medulla in female rats.

J. Ramos, J. Fernández-Ruiz, J. Tresguerres, 1988, Life sciences.

Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.

A. Makriyannis, A. Makriyannis, J. Ramos, 1997, Biochemical pharmacology.

Effects on development.

M. Gómez, J. Ramos, R. de Miguel, 2005, Handbook of experimental pharmacology.

Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3

M. A. Pozo, P. Maciel, C. Hillard, 2016, Neuroscience.

Pharmacological and biochemical interactions between opioids and cannabinoids.

J. Manzanares, J. Ramos, J. Fernández-Ruiz, 1999, Trends in pharmacological sciences.

Pharmacological Activation/Inhibition of the Cannabinoid System Affects Alcohol Withdrawal-Induced Neuronal Hypersensitivity to Excitotoxic Insults

C. Ali, D. Vivien, B. Roussel, 2011, PloS one.

Time-dependent effects of ovarian steroids on tyrosine hydroxylase activity in the limbic forebrain of female rats

J. Ramos, J. Fernández-Ruiz, R. Miguel, 2005, Journal of Neural Transmission / General Section JNT.

Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide.

A. Makriyannis, J. Ramos, J. Fernández-Ruiz, 1999, Life sciences.

Δ9-tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 1997, Journal of Molecular Neuroscience.

Effects of perinatal exposure to Δ9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain

J. Ramos, J. Fernández-Ruiz, R. Miguel, 2007, Journal of Molecular Neuroscience.

Cannabinoid CB1 receptors colocalize with tyrosine hydroxylase in cultured fetal mesencephalic neurons and their activation increases the levels of this enzyme

K. Mackie, F. Berrendero, M. Cebeira, 2000, Brain Research.

The prenatal exposure to delta 9-tetrahydrocannabinol affects the gene expression and the activity of tyrosine hydroxylase during early brain development.

J. Ramos, J. Fernández-Ruiz, R. de Miguel, 1995, Life sciences.

Modifications of mesolimbic and nigrostriatal dopaminergic activities after intracerebroventricular administration of prolactin

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 2005, Journal of Neural Transmission / General Section JNT.

Time-dependent differences of repeated administration with Delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen.

J. Manzanares, F. Berrendero, J. Ramos, 1999, Brain research. Molecular brain research.

Effects of chronic exposure to Δ9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions

J. Ramos, J. Fernández-Ruiz, J. Romero, 1997 .

UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide.

J. Ramos, J. Fernández-Ruiz, M. López-Rodríguez, 2002, European journal of pharmacology.

Design, synthesis and biological evaluation of novel arachidonic acid derivatives as highly potent and selective endocannabinoid transporter inhibitors.

J. Ramos, J. Fernández-Ruiz, M. López-Rodríguez, 2001, Journal of medicinal chemistry.

Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function

J. Ramos, J. Fernández-Ruiz, J. Romero, 1995, Brain Research.

Presence of cannabinoid binding sites in the brain from early postnatal ages.

F. Rodríguez de Fonseca, J. Ramos, J. Fernández-Ruiz, 1993, Neuroreport.

Time-dependent effects of estradiol and progesterone on the number of striatal dopaminergic D2-receptors

J. Ramos, J. Fernández-Ruiz, J. C. Amor, 1989, Brain Research.

Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.

M. Cascio, E. Ambrosio, V. Di Marzo, 2004, Drug and alcohol dependence.

Role of estrogens on striatal dopaminergic activity.

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 1987, Journal of steroid biochemistry.

Downregulation of rat brain cannabinoid binding sites after chronic Δ 9-tetrahydrocannabinol treatment

T. Palomo, J. Ramos, J. Fernández-Ruiz, 1994, Pharmacology Biochemistry and Behavior.

Perinatal delta 9-tetrahydrocannabinol exposure in rats modifies the responsiveness of midbrain dopaminergic neurons in adulthood to a variety of challenges with dopaminergic drugs.

J. Ramos, J. Fernández-Ruiz, L. García, 1996, Drug and alcohol dependence.

Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain.

J. Manzanares, J. Ramos, J. Fernández-Ruiz, 1998, Brain research. Molecular brain research.

Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders

V. Marzo, F. Piscitelli, J. Ramos, 2015, Journal of Neuroimmune Pharmacology.

Characterization of an anandamide degradation system in prostate epithelial PC‐3 cells: synthesis of new transporter inhibitors as tools for this study

M. A. Lasunción, A. M. Sánchez, C. Hillard, 2004, British journal of pharmacology.

Exposure to cannabinoids in the development of endogenous cannabinoid system

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 2002, Neurotoxicity Research.

Cannabinoid receptor binding did not vary in several hypothalamic nuclei after hypothalamic deafferentation.

J. Ramos, J. Fernández-Ruiz, T. Wenger, 1998, Life sciences.

Acute effects of delta 9-tetrahydrocannabinol on tuberoinfundibular dopamine activity, anterior pituitary sensitivity to dopamine and prolactin release vary as a function of estrous cycle.

F. Rodríguez de Fonseca, M. Cebeira, J. Ramos, 1993, Neuroendocrinology.

Neuroendocrine effects of an acute dose of δ9-tetrahydrocannabinol : changes in hypothalamic biogenic amines and anterior pituitary hormone secretion

J. Ramos, Medardo Hernández, M. Navarro, 1992 .

Involvement of GABA(B) receptors in the motor inhibition produced by agonists of brain cannabinoid receptors.

J. Ramos, J. Fernández-Ruiz, J. Romero, 1996, Behavioural pharmacology.

The endogenous cannabinoid system and brain development

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 2000, Trends in Neurosciences.

Prepartum blood lead concentrations linked to subsequent cyclicity in high-producing dairy cows in a non-industrial area

S. Marín, F. López-Gatius, J. Galceran, 2016 .

Synthesis and structure-activity relationships of a new model of arylpiperazines. Part 7: Study of the influence of lipophilic factors at the terminal amide fragment on 5-HT1A affinity/selectivity

María L. López-Rodríguez, Bellinda Benhamú, J. Ramos, 2004 .

Lipid requirements for the structure and function of the fatty acid synthetase complex from Ceratitis capitata.

J. Gavilanes, M. Lizarbe, J. Ramos, 1979, The Journal of biological chemistry.

Effects of Dibutyryl Cyclic AMP and Retinoic Acid on the Differentiation of Dopamine Neurons: Prevention of Cell Death by Dibutyryl Cyclic AMP

M. Mena, M. Casarejos, J. Ramos, 1995, Journal of neurochemistry.

Fatty acid synthetase activity in Mycobacterium smegmatis. Characterization of the acyl carrier protein-dependent elongating system.

J. Odriozola, J. Ramos, K. Bloch, 1977, Biochimica et biophysica acta.

Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: Relevance to Parkinson's disease

R. Mechoulam, J. Ramos, J. Fernández-Ruiz, 2005, Neurobiology of Disease.

The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.

J. Ramos, J. Fernández-Ruiz, J. Romero, 1997, Life sciences.

Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system

I. Ferrer, J. Ramos, J. Fernández-Ruiz, 2018, Biochemical pharmacology.

Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

J. Ramos, J. Fernández-Ruiz, Mariluz Hernández, 2010, CNS neuroscience & therapeutics.

Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period

V. Di Marzo, F. Berrendero, J. Ramos, 1999, Synapse.

Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects

J. Ramos, J. Fernández-Ruiz, M. Moreno‐Martet, 2012, Neuropharmacology.

Neuroprotective effects of phytocannabinoid‐based medicines in experimental models of Huntington's disease

R. Pertwee, J. Ramos, J. Fernández-Ruiz, 2011, Journal of neuroscience research.

Themed Issue: Cannabinoids in Biology and Medicine, Part I

A. Ben-nun, M. Guzmán, C. Guaza, 2011 .

Cannabidiol reduced the striatal atrophy caused 3‐nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors

R. Mechoulam, J. Ramos, J. Fernández-Ruiz, 2007, The European journal of neuroscience.

Cannabinoids in neurodegeneration and neuroprotection

J. Ramos, J. Fernández-Ruiz, J. Romero, 2005 .

Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence

J. Ramos, J. Fernández-Ruiz, E. Lago, 2004, Brain Research.

The endogenous cannabinoid system and the basal ganglia. biochemical, pharmacological, and therapeutic aspects.

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 2002, Pharmacology & therapeutics.

Enhancement of Anandamide Formation in the Limbic Forebrain and Reduction of Endocannabinoid Contents in the Striatum of Δ9‐Tetrahydrocannabinol‐Tolerant Rats

T. Bisogno, V. Marzo, V. Di Marzo, 2000, Journal of neurochemistry.

Cannabinoid receptors in rat brain areas: sexual differences, fluctuations during estrous cycle and changes after gonadectomy and sex steroid replacement.

F. Rodríguez de Fonseca, M. Cebeira, J. Ramos, 1994, Life sciences.

Endocannabinoids and Neurodegenerative Disorders: Parkinson's Disease, Huntington's Chorea, Alzheimer's Disease, and Others.

J. Ramos, J. Fernández-Ruiz, J. Romero, 2015, Handbook of experimental pharmacology.

Alleviation of motor hyperactivity and neurochemical deficits by endocannabinoid uptake inhibition in a rat model of Huntington's disease

J. Manzanares, F. Berrendero, J. Ramos, 2002, Synapse.

Down-regulation of the AMPA glutamate receptor subunits GluR1 and GluR2/3 in the rat cerebellum following pre- and perinatal Δ9-tetrahydrocannabinol exposure

J. Ramos, J. Fernández-Ruiz, G. Bodega, 2008, The Cerebellum.

Motor disturbances induced by an acute dose of Δ 9-tetrahydrocannabinol: Possible involvement of nigrostriatal dopaminergic alterations

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 1993, Pharmacology Biochemistry and Behavior.

Effect of diet on lipogenesis of larvae of Ceratitis capitata

J. Odriozola, J. Ramos, Á. M. Municio, 1973 .

In vitro regulation by nadph of fatty acid biosynthesis with larval and pharate adult homogenates of the fly, Ceratitis capitata

J. Odriozola, J. Ramos, Á. M. Municio, 1972 .

Catecholaminergic control of plasma growth hormone and thyrotropin levels in hypophysectomized rats bearing ectopic pituitary transplants.

A. Bartke, A. Esquifino, M. Cebeira, 1987, Life sciences.

Is prolactin playing a role in the regulation of catecholamine synthesis and release from male rat adrenal medulla?

J. Ramos, J. Fernández-Ruiz, R. Miguel, 1991, Journal of endocrinological investigation.

In vitro and in vivo fate of saturated and unsaturated fatty acids during development of insects.

J. Odriozola, J. Ramos, M. Pérez-Albarsanz, 1974, Biochimica et biophysica acta.

Fatty acid synthetase content during development of the fly, Ceratitis capitata

M. Lizarbe, J. Ramos, Á. M. Municio, 1977 .

Prolactin inhibits the activity of tyrosine hydroxylase in cultured bovine adrenal chromaffin cells in a dose-dependent manner

J. Ramos, J. Fernández-Ruiz, R. Miguel, 1990, Brain Research.

Possible direct effect of prolactin on catecholamine synthesis and release in rat adrenal medulla: in vitro studies

J. Ramos, J. Fernández-Ruiz, R. Martínez-Arrieta, 1988, Journal of endocrinological investigation.

Design, synthesis and biological evaluation of new endocannabinoid transporter inhibitors.

J. Ramos, J. Fernández-Ruiz, M. López-Rodríguez, 2003, European journal of medicinal chemistry.

First pharmacophoric hypothesis for 5-HT7 antagonism.

J. Lavandera, J. Ramos, M. López-Rodríguez, 2000, Bioorganic & medicinal chemistry letters.

CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats

J. Walker, J. Ramos, J. Fernández-Ruiz, 2008, Neuropharmacology.

Changes in endocannabinoid contents in reward‐related brain regions of alcohol‐exposed rats, and their possible relevance to alcohol relapse

M. Valenti, F. Fezza, V. Di Marzo, 2004, British journal of pharmacology.

Prenatal Cannabinoid Exposure Down- Regulates Glutamate Transporter Expressions (GLAST and EAAC1) in the Rat Cerebellum

J. Ramos, J. Fernández-Ruiz, G. Bodega, 2004, Developmental Neuroscience.

Effects of perinatal exposure to Δ9-tetrahydrocannabinol on operant morphine-reinforced behavior

E. Ambrosio, J. Ramos, J. Fernández-Ruiz, 2003, Pharmacology Biochemistry and Behavior.

Effect of elevated prolactin levels on the synthesis and release of catecholamines from the adrenal medulla in female rats.

A. Esquifino, M. Cebeira, J. Ramos, 1987, Neuroendocrinology.

Modifications of striatal D2 dopaminergic postsynaptic sensitivity during development of morphine tolerance-dependence in mice

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 1992, Pharmacology Biochemistry and Behavior.

Chronic Δ9-tetrahydrocannabinol administration affects serotonin levels in the rat frontal cortex

J. Ramos, J. Fernández-Ruiz, M. L. L. Rodríguez, 2005, Naunyn-Schmiedeberg's Archives of Pharmacology.

New serotonin 5-HT(1A) receptor agonists with neuroprotective effect against ischemic cell damage.

L. Pardo, A. Planas, J. Ramos, 2011, Journal of medicinal chemistry.

Changes in prodynorphin and POMC gene expression in several brain regions of rat fetuses prenatally exposed to Δ-tetrahydrocannabinol

J. Manzanares, J. Ramos, A. Pérez‐Rosado, 2009, Neurotoxicity Research.

Perinatal Δ9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats

J. Manzanares, J. Ramos, J. Fernández-Ruiz, 1998 .

Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.

J. Ramos, J. Fernández-Ruiz, M. Ruiz‐Gayo, 1998, Drug and alcohol dependence.

Endocannabinoids and Dopamine-Related Functions in the CNS

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 2005 .

An Overview on the Biochemistry of the Cannabinoid System

J. Ramos, R. Miguel, Mariluz Hernández, 2007, Molecular Neurobiology.

Changes in cannabinoid CB1 receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 2001, Synapse.

Neurochemical effects of the endocannabinoid uptake inhibitor UCM707 in various rat brain regions.

J. Ramos, J. Fernández-Ruiz, S. Ortega‐Gutiérrez, 2007, Life sciences.

Effects of a short-term exposure to alcohol in rats on FAAH enzyme and CB1 receptor in different brain areas.

J. Ramos, J. Fernández-Ruiz, M. Carai, 2009, Drug and alcohol dependence.

Endocannabinoids and basal ganglia functionality.

J. Ramos, J. Fernández-Ruiz, J A Ramos, 2002, Prostaglandins, leukotrienes, and essential fatty acids.

Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development.

F. Berrendero, M. Cebeira, J. Ramos, 1998, Development.

Motor behavior and nigrostriatal dopaminergic activity in adult rats perinatally exposed to cannabinoids

J. Ramos, J. Fernández-Ruiz, F. Fonseca, 1994, Pharmacology Biochemistry and Behavior.

An acute dose of δ9-tetrahydrocannabinol affects behavioral and neurochemical indices of mesolimbic dopaminergic activity

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 1993, Behavioural Brain Research.

Estrogenic modulation of δ 9-Tetrahydrocannabinol effects on nigrostriatal dopaminergic activity in the female rat brain

J. Ramos, F. Fonseca, R. Miguel, 1992, Molecular and Cellular Neuroscience.

Early changes in the development of dopaminergic neurotransmission after maternal exposure to cannabinoids

J. Ramos, J. Fernández-Ruiz, F. Fonseca, 1992, Pharmacology Biochemistry and Behavior.

Effects of pre- and perinatal exposure to hashish extracts on the ontogeny of brain dopaminergic neurons

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 1991, Neuroscience.

Changes in cannabinoid CB(1) receptors in striatal and cortical regions of rats with experimental allergic encephalomyelitis, an animal model of multiple sclerosis.

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 2001, Synapse.

Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPγS binding and cannabinoid receptor mRNA levels in several brain structures of adult male rats chronically exposed to R-methanandamide

A. Makriyannis, S. Lin, F. Berrendero, 1999, Neurochemistry International.

Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs.

A. Makriyannis, A. Makriyannis, J. Ramos, 1998, Biochemical pharmacology.

Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand.

A. Makriyannis, S. Lin, J. Ramos, 1996, Life sciences.

Effects of anandamide on hepatic fatty acid metabolism.

G. Velasco, M. Guzmán, C. Sánchez, 1995, Biochemical pharmacology.

Arvanil, a hybrid endocannabinoid and vanilloid compound, behaves as an antihyperkinetic agent in a rat model of Huntington's disease

V. Marzo, J. Ramos, J. Fernández-Ruiz, 2005, Brain Research.

Determination of plasma haloperidol concentrations by radioreceptor assay in schizophrenia: Clinical utility

C. Vázquez, J. Cabranes, J. Santos, 1989, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

2-Hydroxyestradiol is not mediating the effects of estradiol on tuberoinfundibular dopaminergic neurons controlling prolactin secretion in female rats.

J. Ramos, J. Fernández-Ruiz, C. Alvarez-Sanz, 1989, Journal of steroid biochemistry.

Maternal exposure to Δ9-tetrahydrocannabinol facilitates morphine self-administration behavior and changes regional binding to central μ opioid receptors in adult offspring female rats

E. Ambrosio, J. Ramos, D. Pélaprat, 1998, Brain Research.

Possible role of dopamine in changes in LH and prolactin concentrations after experimentally induced hyperprolactinaemia in rats.

A. Esquifino, J. Ramos, J. Tresguerres, 1984, The Journal of endocrinology.

Lack of effect of prolactin on the dopaminergic receptor sensitivity in striatal and limbic areas after experimentally-induced alterations in its peripheral levels.

F. Rodríguez de Fonseca, M. Cebeira, J. Ramos, 1991, Life sciences.

Nigrostriatal and mesolimbic dopaminergic activities were modified throughout the ovarian cycle of female rats

J. Ramos, J. Fernández-Ruiz, R. Miguel, 2005, Journal of Neural Transmission / General Section JNT.

Time-course of the effects of ovarian steroids on the activity of limbic and striatal dopaminergic neurons in female rat brain

J. Ramos, J. Fernández-Ruiz, R. Miguel, 1990, Pharmacology Biochemistry and Behavior.

Perinatal cannabinoid exposure modifies the sociosexual approach behavior and the mesolimbic dopaminergic activity of adult male rats

J. Ramos, J. Fernández-Ruiz, F. Fonseca, 1996, Behavioural Brain Research.

Therapeutic potential of the endocannabinoid system in the brain.

J. Ramos, J. Fernández-Ruiz, S. González, 2005, Mini-Reviews in Medical Chemistry.

Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen.

J. Manzanares, F. Berrendero, J. Ramos, 2000, Life sciences.

Acute effects of δ-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 1992, Pharmacology Biochemistry and Behavior.

Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35s]guanylyl-5′-O-(thio)-triphosphate binding in the basal ganglia of aged rats

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 1998, Neuroscience.

Changes in brain dopaminergic indices induced by perinatal exposure to cannabinoids in rats.

F. Rodríguez de Fonseca, M. Cebeira, J. Ramos, 1990, Brain research. Developmental brain research.

δ9-Tetrahydrocannabinol affects mesolimbic dopaminergic activity in the female rat brain: interactions with estrogens

J. Ramos, J. Fernández-Ruiz, F. Fonseca, 2005, Journal of Neural Transmission / General Section JNT.

Loss of cannabinoid CB1 receptors in the basal ganglia in the late akinetic phase of rats with experimental Huntington’s disease

J. Ramos, J. Fernández-Ruiz, I. Lastres-Becker, 2002, Neurotoxicity Research.

Possible role of the cytochrome P450-linked monooxygenase system in preventing delta 9-tetrahydrocannabinol-induced stimulation of tuberoinfundibular dopaminergic activity in female rats.

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 1994, Biochemical pharmacology.

Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTPγS binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to Δ9-tetrahydrocannabinol

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 1998, Journal of Molecular Neuroscience.

Role of endocannabinoids in brain development.

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 1999, Life sciences.

Prenatal cannabinoid exposure and gene expression for neural adhesion molecule L1 in the fetal rat brain

M. Gómez, J. Ramos, J. Fernández-Ruiz, 2003 .

Prenatal Δ9-tetrahydrocannabinol exposure modifies proenkephalin gene expression in the fetal rat brain: sex-dependent differences

J. Manzanares, J. Ramos, J. Fernández-Ruiz, 2000 .

Cannabinoids and gene expression during brain development

J. Ramos, J. Fernández-Ruiz, R. Miguel, 2009, Neurotoxicity Research.

Perinatal Δ9-Tetrahydrocannabinol Exposure Did Not Alter Dopamine Transporter and Tyrosine Hydroxylase mRNA Levels in Midbrain Dopaminergic Neurons of Adult Male and Female Rats

T. Rubino, D. Parolaro, J. Ramos, 1998 .

Atypical location of cannabinoid receptors in white matter areas during rat brain development

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 1997, Synapse.

Changes in tyrosine hydroxylase gene expression in mesencephalic catecholaminergic neurons of immature and adult male rats perinatally exposed to cannabinoids.

J. Ramos, J. Fernández-Ruiz, J. C. Rodríguez-Manzaneque, 1994, Brain research. Developmental brain research.

Reduced Glial Fibrillary Acidic Protein and Glutamine Synthetase Expression in Astrocytes and Bergmann Glial Cells in the Rat Cerebellum Caused by Δ9-Tetrahydrocannabinol Administration during Development

J. Ramos, J. Fernández-Ruiz, G. Bodega, 2002, Developmental Neuroscience.

Perinatal delta9-tetrahydrocannabinol exposure augmented the magnitude of motor inhibition caused by GABA(B), but not GABA(A), receptor agonists in adult rats.

J. Ramos, J. Fernández-Ruiz, J. Romero, 1999, Neurotoxicology and teratology.

Perinatal delta(9)-tetrahydrocannabinol exposure alters the responsiveness of hypothalamic dopaminergic neurons to dopamine-acting drugs in adult rats.

M. Cebeira, J. Ramos, J. Fernández-Ruiz, 1997, Neurotoxicology and teratology.

Cannabinoid CB1 receptors in the basal ganglia and motor response to activation or blockade of these receptors in parkin-null mice

M. Mena, J. Ramos, J. Fernández-Ruiz, 2005, Brain Research.

Unilateral 6-Hydroxydopamine Lesions of Nigrostriatal Dopaminergic Neurons Increased Cannabinoid CB1 Receptor mRNA Levels in the Rat Striatum: Possible Therapeutic Implications

J. Manzanares, F. Berrendero, J. Ramos, 2000 .

In vitro regulation of enzymes of the fatty acid synthesis in liver from adult and fetal rabbits

J. Odriozola, J. Ramos, M. Pérez-Albarsanz, 1974 .

Lipogenesis from [14C]acetate during development of Ceratitis capitata

J. Odriozola, J. Ramos, Á. M. Municio, 1974 .

Blockade of cannabinoid CB1 receptor function protects against in vivo disseminating brain damage following NMDA‐induced excitotoxicity

L. Garcia-Segura, Í. Azcoitia, S. Pons, 2002, Journal of neurochemistry.

Role of CB2 receptors in neuroprotective effects of cannabinoids

M. García-Arencibia, J. Ramos, J. Fernández-Ruiz, 2008, Molecular and Cellular Endocrinology.

UCM707, an inhibitor of the anandamide uptake, behaves as a symptom control agent in models of Huntington's disease and multiple sclerosis, but fails to delay/arrest the progression of different motor-related disorders

D. Baker, J. Ramos, J. Fernández-Ruiz, 2006, European Neuropsychopharmacology.

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington’s disease

J. Lucas, F. Berrendero, J. Ramos, 2002, Brain Research.

Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington's disease

T. Bisogno, V. Marzo, F. Fezza, 2001, Neuroreport.

[Pharmacokinetic and pharmacodynamic aspects of L-DOPA treatment and dopadecarboxilase inhibitors and dopaminergic antagonists in Parkinson's disease (author's transl)].

M. Mena, J. Ramos, J. García de Yébenes, 1982, Medicina clinica.

Altered striatal endocannabinoid signaling in a transgenic mouse model of spinocerebellar ataxia type-3

P. Maciel, C. Hillard, J. Ramos, 2017, PloS one.

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: Importance of antioxidant and cannabinoid receptor-independent properties

M. García-Arencibia, R. Mechoulam, J. Ramos, 2007, Brain Research.

Role of ovarian steroids on the catecholamine synthesis and release in female rat adrenal: in vivo and in vitro studies.

J. Ramos, J. Fernández-Ruiz, M. Hernández, 1989, Life sciences.

Dysregulation of the endocannabinoid signaling system in the cerebellum and brainstem in a transgenic mouse model of spinocerebellar ataxia type-3

M. A. Pozo, P. Maciel, C. Hillard, 2016, Neuroscience.

Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB1 receptor-mediated anti-inflammatory effects

J. Ramos, J. Fernández-Ruiz, M. Moreno‐Martet, 2012, Neuropharmacology.

Effects of chronic exposure to delta9-tetrahydrocannabinol on cannabinoid receptor binding and mRNA levels in several rat brain regions.

J. Ramos, J. Fernández-Ruiz, J. Romero, 1997, Brain research. Molecular brain research.

New serotonin 5-HT1A receptor agonists endowed with antinociceptive activity in vivo.

J. Ramos, M. López-Rodríguez, B. Benhamú, 2013, Journal of medicinal chemistry.

Changes in cannabinoid receptor binding and mRNA levels in several brain regions of aged rats.

F. Berrendero, J. Ramos, J. Fernández-Ruiz, 1998, Biochimica et biophysica acta.

Prenatal cannabinoid and gene expression for neural adhesion molecule L1 in the fetal rat brain.

J. Ramos, J. Fernández-Ruiz, B. Johansson, 2003, Brain research. Developmental brain research.

Region‐dependent changes in endocannabinoid transmission in the brain of morphine‐dependent rats

R. Krebsbach, H. Schmid, J. Ramos, 2003, Addiction biology.